VUS: variant of uncertain significance; rrBSO: risk-reducing bilateral salpingo-oophorectomy.
* Ensure that the genetic testing is performed properly, the patient identification is correct, and the interpretation of pathogenicity is accurate based on the most recent data analysis.
¶ Pathogenic and likely pathogenic variants are treated the same for purposes of surveillance and risk-reduction interventions; these interventions are independent of family history.
Δ VUSs lack sufficient information from clinical and bench research to be classified as pathogenic or benign. Continue to seek updated interpretation of pathogenicity periodically (eg, annually).
◊ Refer to UpToDate for the age at which interventions are initiated (eg, delay of rrBSO until after childbearing), the frequency at which they are performed, and the supporting evidence.